ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 67 filers reported holding ASTRIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $293,041 | +5.7% | 20,820 | -42.3% | 0.00% | 0.0% |
| Q4 2023 | $277,248 | -21.8% | 36,100 | -24.0% | 0.00% | -33.3% |
| Q3 2023 | $354,350 | -8.5% | 47,500 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $387,345 | -44.9% | 46,500 | -12.0% | 0.00% | -57.1% |
| Q1 2023 | $702,731 | +27.2% | 52,837 | +42.4% | 0.01% | +40.0% |
| Q4 2022 | $552,419 | +617.4% | 37,100 | +222.6% | 0.01% | +400.0% |
| Q1 2022 | $77,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 3,554,129 | $32,342,574 | 3.65% |
| TCG Crossover Management, LLC | 2,761,861 | $25,132,935 | 2.62% |
| Vestal Point Capital, LP | 3,250,000 | $29,575,000 | 2.20% |
| VR Adviser, LLC | 3,608,645 | $32,838,670 | 2.09% |
| Vivo Capital, LLC | 2,329,027 | $21,194,146 | 1.96% |
| Perceptive Advisors | 6,485,420 | $59,017,322 | 1.42% |
| Sio Capital Management, LLC | 510,267 | $4,643,430 | 1.26% |
| Affinity Asset Advisors, LLC | 975,606 | $8,878,015 | 1.02% |
| RA Capital Management | 5,043,756 | $45,898,180 | 0.61% |
| DAFNA Capital Management LLC | 274,165 | $2,494,902 | 0.60% |